Morning Breakouts

Latest California Healthline Stories

Medicare Conferees Consider Proposal To Charge Higher Premiums for Higher-Income Beneficiaries

Negotiators charged with reconciling the House and Senate Medicare bills (HR 1 and S 1) are “seriously considering” requiring beneficiaries with higher incomes to pay higher premiums than other beneficiaries, the New York Times reports.

Davis Signs Employer-Sponsored Health Coverage Bill

As expected, Gov. Gray Davis (D) on Sunday signed a bill (SB 2) that will require some employers in the state to either provide health insurance to employees or pay into a state fund that would provide such coverage, the Wall Street Journal reports.

Davis, Gubernatorial Recall Candidates’ Policy Positions Featured

The San Francisco Chronicle and the Los Angeles Times recently featured the positions of Gov. Gray Davis (D) and gubernatorial recall candidates Lt. Gov. Cruz Bustamante (D), Arnold Schwarzenegger (R), Sen. Tom McClintock (R-Thousand Oaks) and Green Party candidate Peter Camejo on policy issues, including health care.

Schwarzenegger Healthy Families Criticism Inaccurate, Editorial Says

The expansion of Healthy Families, which offers health insurance to children in families that do qualify for Medicaid, is one of the “clear successes” of Gov. Gray Davis’ (D) tenure, which makes Republican gubernatorial candidate Arnold Schwarzenegger’s comments about Davis’ handling of the program “bizarre,” a San Francisco Chronicle editorial states.

Senate Bill To Allow FDA Regulation of Tobacco Products Could Pass This Year, Supporters Say

Republican supporters of a Senate bill that would allow the FDA to regulate tobacco products on Thursday said that efforts to pass the legislation this year are “not dead,” despite disagreements with opponents who maintain that the bill is “not strong enough,” CongressDaily reports.

FDA Task Force Outlines Proposal To Combat Counterfeit Medications

The FDA Counterfeit Drug Task Force on Thursday unveiled a draft report on potential measures to combat counterfeit drugs in the United States, a move that could “broadly reshape how medicines are packaged and distributed,” the Wall Street Journal reports.